Health Secretary Matt Hancock speaks at Downing Street press conference

Bethany inquires about the prioritization of vaccines for those shielding but under 65. The Health Secretary explains that the Joint Committee on Vaccinations and Immunizations advises on clinical priorities, considering those clinically vulnerable. Interim guidance is based on current data from leading vaccines, with updates expected as more data becomes available.

What is the main concern raised by Bethany regarding the vaccine prioritization?

• The prioritization of those shielding under 65

• The availability of the vaccine in rural areas

• The effectiveness of the vaccine

• The cost of the vaccine

Who advises the health secretary on the clinical priority for vaccines?

• National Institutes of Health

• Joint Committee on Vaccinations and Immunizations

• Centers for Disease Control and Prevention

• World Health Organization

Which two vaccines are mentioned as leading candidates in the interim prioritization?

• Novavax and Bharat Biotech

• Sinovac and Sputnik V

• Pfizer and AstraZeneca

• Moderna and Johnson & Johnson

What does the clinical judgment process take into account?

• The cost of the vaccine

• The distribution logistics

• The manufacturing process

• The risk level of clinically vulnerable individuals

Who is mentioned as providing additional input on the clinical judgment process?

• Tedros Adhanom

• Jonathan Van Tam

• Albert Bourla

• Anthony Fauci